Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas

TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma

(2012) D. W. Scott et al.   BLOOD

Peripheral T-cell lymphoma

(2011) F. M. Foss et al.   BLOOD

 Np63 Regulates Stem Cell Dynamics in the Mammalian Olfactory Epithelium

(2011) A. Packard et al.   JOURNAL OF NEUROSCIENCE

Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11

(2011) J E Noll et al.   ONCOGENE

Dominant negative (ΔN) p63α induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways

(2010) Heiko M. Mundt et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

(2010) A. L. Feldman et al.   BLOOD

ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time

(2010) David E. Gerber et al.   CANCER CELL

Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly(ADP-Ribose) Polymerase Inhibition, Gemcitabine, and Cisplatin

(2010) K. Hastak et al.   CANCER RESEARCH

Development and validation of a comprehensive mutation and deletion detection assay for SDHB, SDHC, and SDHD

(2010) Dragana Milosevic et al.   CLINICAL BIOCHEMISTRY

Primary Cutaneous CD30+ Anaplastic Large-Cell Lymphomas Show a Heterogeneous Genomic Profile: An Oligonucleotide ArrayCGH Approach

(2010) Júlia Ma Sánchez-Schmidt et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Identification of ΔNp63α Protein Interactions by Mass Spectrometry

(2010) Angela Amoresano et al.   JOURNAL OF PROTEOME RESEARCH

CDKN2A–CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma

(2010) Elodie Laharanne et al.   MODERN PATHOLOGY

Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies

(2010) David A Wada et al.   MODERN PATHOLOGY

TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs

(2010) Xiaohua Su et al.   NATURE

The significance ofTP53in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target

(2009) K-John J. Cheung et al.   BRITISH JOURNAL OF HAEMATOLOGY

TAp63 induces senescence and suppresses tumorigenesis in vivo

(2009) Xuecui Guo et al.   NATURE CELL BIOLOGY

Incidence ofTCRandTCL1Gene Translocations and Isochromosome 7q in Peripheral T-Cell Lymphomas Using Fluorescence In Situ Hybridization

(2008) Andrew L. Feldman et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

(2008) K. J. Savage et al.   BLOOD

Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation

(2008) Luciano J. Costa et al.   BRITISH JOURNAL OF HAEMATOLOGY

Therapeutic prospects for p73 and p63: Rising from the shadow of p53

(2008) Anna Vilgelm et al.   DRUG RESISTANCE UPDATES

Identification of ANKRD11 as a p53 coactivator

(2008) P. M. Neilsen et al.   JOURNAL OF CELL SCIENCE

Overexpression of ΔNp63 in a human nasopharyngeal carcinoma cell line downregulates CKIs and enhances cell proliferation

(2008) Chi-Tai Chiang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas

(2008) A L Feldman et al.   LEUKEMIA

Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas

(2008) A L Feldman et al.   LEUKEMIA